{"title":"[替托品治疗哮喘——一个新的机会?]。","authors":"Florin Mihălţan, Ruxandra Ulmeanu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Tiotropium, after years of study, began to find place among asthma medications. The authors analyze all the benefits and limitations of existing studies and try to position the 2014 indications of tiotropium in two types of conditions: asthma-COPD overlap syndrome and moderate and severe asthma.</p>","PeriodicalId":20345,"journal":{"name":"Pneumologia","volume":"63 4","pages":"200-2"},"PeriodicalIF":0.0000,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Tiotropium in asthma--a new opportunity?].\",\"authors\":\"Florin Mihălţan, Ruxandra Ulmeanu\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Tiotropium, after years of study, began to find place among asthma medications. The authors analyze all the benefits and limitations of existing studies and try to position the 2014 indications of tiotropium in two types of conditions: asthma-COPD overlap syndrome and moderate and severe asthma.</p>\",\"PeriodicalId\":20345,\"journal\":{\"name\":\"Pneumologia\",\"volume\":\"63 4\",\"pages\":\"200-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pneumologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pneumologia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Tiotropium, after years of study, began to find place among asthma medications. The authors analyze all the benefits and limitations of existing studies and try to position the 2014 indications of tiotropium in two types of conditions: asthma-COPD overlap syndrome and moderate and severe asthma.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
